Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Institute, we value our team members and are proud to offer an extensive range of benefits to support their well-being and development: Visas: Applicants for this role will be eligible for sponsorship to work
-
Infection (CiViA) at Aarhus University (Denmark, https://biomed.au.dk/civia) • MHH, TWINCORE and HZI have a strong research focus on “Infection and Immunity” and host the German Excellence Cluster
-
care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing
-
founded the Rowland Institute of Science in 1982 to foster high-risk, creative research. In 2002, we became the Rowland Institute at Harvard when we joined the University with the mission of advancing
-
autoimmunity. The overarching goal of the Wu lab is to harness innate immunity to develop new immunotherapies for cancer and inflammatory diseases. Our recent research has been published in top-tier journals
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
call for participation in the SQUASH program – the Slovenian Quantum Science Hub. This is an innovative, intersectoral training and career-development program, co-funded by the Marie Skłodowska-Curie
-
The University of Toronto is pleased to announce the third call for applications for theEric and Wendy Schmidt AI in Science Postdoctoral Fellowship , a program of Schmidt Sciences, which brings
-
and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique, comprehensive mouse models for: 1) real-time labeling and
-
to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4) development of small molecule drugs and PROTAC